1,4-BENZENEDISULFONIC ACID, 2-(2-(4-(2-(4-((4-CHLORO-6-(PHENYL(SULFOMETHYL)AMINO)-1,3,5-TRIAZIN-2-YL)AMINO)-7-SULFO-1-NAPHTHALENYL)DIAZENYL)-5-METHOXY-2-METHYLPHENYL)DIAZENYL)-, SODIUM SALT (1:4)
UNII ALX37V5PZQ
Substance Identification & Data
This profile provides standardized clinical and technical data for 1,4-benzenedisulfonic Acid, 2-(2-(4-(2-(4-((4-chloro-6-(phenyl(sulfomethyl)amino)-1,3,5-triazin-2-yl)amino)-7-sulfo-1-naphthalenyl)diazenyl)-5-methoxy-2-methylphenyl)diazenyl)-, Sodium Salt (1:4), uniquely identified by the FDA Unique Ingredient Identifier (UNII) ALX37V5PZQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 29779-15-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C34H24ClN9O13S4.4Na GYJVNJFBOLPDEO-INRNMLHDSA-J Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1,4-benzenedisulfonic Acid, 2-(2-(4-(2-(4-((4-chloro-6-(phenyl(sulfomethyl)amino)-1,3,5-triazin-2-yl)amino)-7-sulfo-1-naphthalenyl)diazenyl)-5-methoxy-2-methylphenyl)diazenyl)-, Sodium Salt (1:4). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.